Skip to content

CareDx CDNA Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$86.6MBeat by $2.0M
EPS$0.18Beat by $0.13
Revenue estimate$84.6M
EPS estimate$0.05

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$113.8M
EPS estimate$0.22

Financials

Q4 2024

Income statement

See full
Revenue$86.6M+32.0%
Operating income$84.4M+169%
Net income$87.7M+174%
EPS (diluted)$1.60+173%

Balance sheet

See full
Cash & equivalents$115.3M+39.2%
Total debt$28.4M-17.1%
Total equity$378.4M+44.8%
Total assets$491.1M+5.2%

Cash flow

See full
Operating cash flow$21.9M+361%
CapEx$158.3K-2.2%
Free cash flow$9.4M+297%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$1.15B+76.9%
Enterprise value$1.06B+76.7%
P/E21.9×
P/S3.4×+1.1×

Profitability

See full
Operating margin12.2%+6.6pp
Net margin15.7%+8.7pp
FCF margin11.2%+8.1pp

Returns & leverage

See full
Return on equity16.4%+9.3pp
Debt / equity0.1×-0.1×
Current ratio3.9×-0.1×

Segments

By product

See full
Testing services revenue$63.8M+36.6%
Patient and digital solutions revenue$11.4M+18.4%

By segment

See full
Reportable Segment$86.6M+23.5%

Versus estimates

Ask the moment CareDx reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did CareDx report Q4 2024 earnings?
CareDx (CDNA) reported Q4 2024 earnings on February 26, 2025 after market close.
What were CareDx's Q4 2024 revenue and EPS?
CareDx reported revenue of $86.6M and eps of $0.18 for Q4 2024.
Did CareDx beat estimates in Q4 2024?
Revenue beat the consensus estimate of $84.6M by $2.0M. EPS beat the consensus estimate of $0.05 by $0.13.
Where can I find CareDx's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001217234-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.